Values for preventing influenza-related morbidity and vaccine adverse events in children.
about
Autism spectrum disorders: a review of measures for clinical, health services and cost-effectiveness applicationsThe impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based studyCost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United StatesCommunity-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse eventsAssessing households' willingness to pay for an immediate pandemic influenza vaccination programme.Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients.From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.Seasonal influenza vaccination for children in Thailand: a cost-effectiveness analysisHealth benefits, risks, and cost-effectiveness of influenza vaccination of children.Evidence of spillover of illness among household members: EQ-5D scores from a US sample.Valuing human leptospirosis prevention using the opportunity cost of labor.Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approachOrdering errors, objections and invariance in utility survey responses: a framework for understanding who, why and what to do.Methodological and applied concerns surrounding age-related weighting within health economic evaluation.Using a discrete choice experiment to elicit time trade-off and willingness-to-pay amounts for influenza health-related quality of life at different ages.Influence of the child's perceived general health on the primary caregiver's health status.Is the societal approach wide enough to include relatives? Incorporating relatives' costs and effects in a cost-effectiveness analysis.Measuring health and well-being effects in family caregivers of children with craniofacial malformations.
P2860
Q27004613-FC477A82-0B5F-4D83-8343-8B4CFE0BB999Q30400700-877E239A-775A-4674-89C7-C8BC37C8343FQ30405846-DAAD80E4-FC37-41D1-864D-E4D4A43A348FQ30411141-9D0E3F4F-FFE9-4759-964C-E861C41F9A86Q30419211-9507644F-E8DB-4E79-BA87-3299857F0BADQ30429017-63AED427-36C2-4359-A986-7F4C162BEA6BQ34613417-12D16960-56DC-4A4D-9798-FE5DF3269AC3Q35642206-F0786983-D117-4F0C-A872-03348EC02056Q35792094-12F70202-98F4-4E0C-87AD-55C77F12E00AQ36711872-BE82F4A1-4131-4940-8E59-845D4D3C9373Q37005808-13630F12-B08C-4D01-BF4F-438C8E7045A0Q37713755-C79750D2-521B-4E2A-937F-2516CA739D32Q37891049-7C70B1C6-9A8F-402F-903A-4B1AB8D342A6Q39157429-25866C3E-F40F-4725-ABDD-BC8543E72B8AQ44320382-9D467276-BFDA-41F8-9EB8-E26E0F31E972Q47659067-AA6A73EE-211A-48B5-BCDD-51FD4AEA7D71Q48923729-355BC1BD-C539-4933-A77E-24BB9F97A36CQ53048553-E3D6BE4D-69CC-4831-A5C1-14BC1ABD561E
P2860
Values for preventing influenza-related morbidity and vaccine adverse events in children.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Values for preventing influenza-related morbidity and vaccine adverse events in children
@nl
Values for preventing influenza-related morbidity and vaccine adverse events in children.
@ast
Values for preventing influenza-related morbidity and vaccine adverse events in children.
@en
type
label
Values for preventing influenza-related morbidity and vaccine adverse events in children
@nl
Values for preventing influenza-related morbidity and vaccine adverse events in children.
@ast
Values for preventing influenza-related morbidity and vaccine adverse events in children.
@en
prefLabel
Values for preventing influenza-related morbidity and vaccine adverse events in children
@nl
Values for preventing influenza-related morbidity and vaccine adverse events in children.
@ast
Values for preventing influenza-related morbidity and vaccine adverse events in children.
@en
P2093
P2860
P356
P1476
Values for preventing influenza-related morbidity and vaccine adverse events in children.
@en
P2093
Benjamin Schwartz
Carolyn Buxton Bridges
G Thomas Ray
Keiji Fukuda
Lisa A Prosser
Tracy A Lieu
Virginia H Rêgo
William W Thompson
P2860
P2888
P356
10.1186/1477-7525-3-18
P407
P577
2005-03-21T00:00:00Z
P5875
P6179
1052725975